Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00754091 · ClinicalTrials.gov registry record · Phase 1

Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy

A Phase 1 study of Healthy Subjects, sponsored by Procter and Gamble.

Completed
Registry status
Phase 1
Development phase
16
Enrollment target
1
Study location

NCT00754091 is a Phase 1 study of Healthy Subjects that has completed, run by Procter and Gamble. The registered enrollment target is 16 participants, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00754091, a Phase 1 study of Healthy Subjects, has completed, sponsored by Procter and Gamble.

COMPLETED
Registry status
Phase 1
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

Single usage, open label study in 16 adult healthy males. Eligible subjects will receive a single usage of the investigational device. Retention of the radiolabeled device will be monitored using gamma scintigraphy.

Conditions Studied

Healthy Subjects

Interventions

  • DEVICE Polymer based lubricating liquid

Study Locations (1)

Kentucky

  • Walter J Doll, PhD, RPh - Lexington

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2008-06
Est. Completion 2008-06
Phase Phase 1

Sponsor

Procter and Gamble

70 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00754091

The ClinicalTrials.gov registry entry for NCT00754091 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (87% lower). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which Polymer based lubricating liquid is the first listed.

NCT00754091 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT00754091 about?

NCT00754091 is a clinical study titled "Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy". Single usage, open label study in 16 adult healthy males. Eligible subjects will receive a single usage of the investigational device. Retention of the radiolabeled device will be monitored using gamma scintigraphy.

What is the current status of trial NCT00754091?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2008-06. Estimated completion is 2008-06.

What conditions does trial NCT00754091 study?

This clinical trial studies the following conditions: Healthy Subjects.

What interventions are being tested in trial NCT00754091?

The interventions under investigation include: Polymer based lubricating liquid (DEVICE).

Who is sponsoring clinical trial NCT00754091?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00754091 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy Subjects

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy Subjects

All registered trials for this condition

Kentucky

All trials with a study site in Kentucky

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.